Figma acquires a team developing a biometric coding app

Figma is trying to become more than just a design platform by adding more AI and bringing the programming and prototyping layer closer to its canvas. To this end, it has acquired the team behind the crypto and AI proxy platform bud (formerly Orchids).

“Figma is one of the defining product companies of our time, if not the pioneer, to capitalize on this. It’s the place where ideas start, iterate, and come to life, and it’s a natural home for this exciting new era of work,” Bud CEO Kevin Lo Published on X.

The Y Combinator-backed startup began as a biocoding platform that allows users to create apps for mobile, web, Slack, browser, and more. Later rebranded as Bud, it is an agent platform that can access various services, browse the web, and write code to automate tasks.

Under the deal, the startup will shut down both Bud and Orchids by July 18, requiring users to migrate their projects by then.

Earlier this year, citing a security researcher, the BBC reported that apps created on… Orchids have been vulnerable to cyber attacks.

Figma hasn’t specified how it aims to use this team, but recent product launches indicate that the overall company wants to give teams more tools to build and prototype apps, not just think about static concepts. Last year, it was released Figma Make for creating web applications. This year, it has been integrated with tools like Codex and Claude Codeand It put forward its own agents.